Displaying 5361 - 5380 of 5993
| Contract Number | Brand Code | Brand Name | Active Ingredient | Trade Name | Package Size | Formulary Category | Pkg Price | Unit Price | Unit Description | Max. Reimbursable Quantity / Month | Package Description | Manufacturer Code | Manufacturer Name | Agent Code | Agent Name | Benefit | Therapeutic Code | Therapeutic Desc | Drug Contract Start Date | Drug Contract End Date | Status Description | Default Route | Max Repeats | Therapeutic Head | Amend Date | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41 | A681GW | BIKTARVY 50MG|200MG|25MG TAB (GIL) BICTEGRAVIR|EMTRICITABINE (BL) | BICTEGRAVIR|EMTRICITABINE|TENOFOVIR | BIKTARVY | 30'S | BL | 290.83 | 9.6944 | TAB | 60 | BOX | GIL | GILEAD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 42 | A681GW | BIKTARVY 50MG|200MG|25MG TAB (GIL) BICTEGRAVIR|EMTRICITABINE | BICTEGRAVIR|EMTRICITABINE|TENOFOVIR | BIKTARVY | 30'S | BL | 290.83 | 9.69 | TAB | 60 | BLIS | GIL | GILEAD | COL | AVENTA BARBADOS | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2026-04-01 | 2028-03-31 | ORAL | 0 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 40 | A681GX | GENVOYA 150MG | 150MG | 200MG | 10MG TAB (GIL/COL) COBICSTAT | ELVITEGRAVIR | EM More ... | COBICSTAT|ELVITEGRAVIR|EMTRICITABINE|TENOFOVIR | GENVOYA | 30'S | BL | 321.99 | 10.73 | TABLET | 0 | TAB | GIL | GILEAD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681GX | GENVOYA 150MG|150MG|200MG|10MG TAB (GIL) COBICSTAT|ELVITEGRA (BL) | COBICSTAT|ELVITEGRAVIR|EMTRICITABINE|TENOFOVIR | GENVOYA | 30'S | BL | 321.99 | 10.7329 | TAB | 60 | BOX | GIL | GILEAD | COL | COLLINS LTD | 08180812 | INTEGRASE INHIBITORS | 2024-04-01 | 2026-03-31 | ORAL | 6 | INTEGRASE INHIBITORS | |||||
| 42 | A681GX | GENVOYA 150MG|150MG|200MG|10MG TAB (GIL) COBICSTAT|ELVITEGRA | COBICSTAT|ELVITEGRAVIR|EMTRICITABINE|TENOFOVIR | GENVOYA | 30'S | BL | 321.99 | 10.73 | TAB | 60 | BLIS | GIL | GILEAD | COL | AVENTA BARBADOS | 08180812 | INTEGRASE INHIBITORS | 2026-04-01 | 2028-03-31 | ORAL | 0 | INTEGRASE INHIBITORS | 2026-02-16 | ||||
| 40 | A681HB | ZOVILAM 150MG | 300MG TAB (MAT/AHI) LAMIVUDINE | ZIDOVUDINE | LAMIVUDINE|ZIDOVUDINE | ZOVILAM | 60'S | BL | 21.20 | 0.35 | TABLET | 0 | TAB | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681HB | ZOVILAM 150MG|300MG TAB (MAT) LAMIVUDINE|ZIDOVUDINE (BL) | LAMIVUDINE|ZIDOVUDINE | ZOVILAM | 60'S | BL | 30.17 | 0.5029 | TAB | 60 | BOX | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180820 | NRTI | 2024-04-01 | 2026-03-31 | ORAL | 6 | NRTI | |||||
| 40 | A681HC | EFAVIRENZ | EMTRICITABINE | TENOFOVIR 600MG | 200MG | 300MG TAB (MCP/AHI) | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | 30'S | BL | 21.80 | 0.73 | TABLET | 0 | TAB | MCP | MACLEODS PHARMACEUTICALS LTD | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681HC | EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MCP (BL) | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | 30'S | BL | 19.19 | 0.6397 | TAB | 60 | BOX | MCP | MACLEODS PHARMACEUTICALS LTD | AHI | ARMSTRONG HEALTHCARE INC | 08180816 | NNRTI | 2024-04-01 | 2026-03-31 | ORAL | 6 | NNRTI | |||||
| 42 | A681HC | EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MCP | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | 30'S | BL | 16.31 | 0.54 | TAB | 60 | BLIS | MCP | MACLEODS PHARMACEUTICALS LTD | AHI | ARMSTRONG HEALTHCARE INC | 08180816 | NNRTI | 2026-04-01 | 2028-03-31 | ORAL | 0 | NNRTI | |||||
| 42 | A681HD | ATAZANAVIR|RITONAVIR 300MG|100MG TA | ATAZANAVIR|RITONAVIR | ATAZANAVIR|RITONAVIR | 30'S | BL | 61.16 | 2.04 | TAB | 60 | BOTT | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180820 | NRTI | 2026-04-01 | 2028-03-31 | ORAL | 0 | NRTI | |||||
| 40 | A681HE | ABACAVIR | LAMIVUDINE 600MG | 300MG TAB (MAT/AHI) | ABACAVIR|LAMIVUDINE | ABACAVIR|LAMIVUDINE | 30'S | BL | 63.61 | 2.12 | TABLET | 0 | TAB | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 40 | A681HG | DUOVIR 150MG | 300MG TAB (CIP/AHI) LAMIVUDINE | ZIDOVUDINE | LAMIVUDINE|ZIDOVUDINE | DUOVIR | 60'S | BL | 53.47 | 0.89 | TABLET | 0 | TAB | CIP | CIPLA LTD | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 40 | A681HJ | EMTRICITABINE | TENOFOVIR 200MG | 300MG TAB (MCP/AHI) | EMTRICITABINE|TENOFOVIR | EMTRICITABINE|TENOFOVIR | 30'S | BL | 15.98 | 0.53 | TABLET | 0 | TAB | MCP | MACLEODS PHARMACEUTICALS LTD | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681HJ | EMTRICITABINE|TENOFOVIR 200MG|300MG TAB (MCP) (BL) | EMTRICITABINE|TENOFOVIR | EMTRICITABINE|TENOFOVIR | 30'S | BL | 13.24 | 0.4413 | TAB | 60 | BOX | MCP | MACLEODS PHARMACEUTICALS LTD | AHI | ARMSTRONG HEALTHCARE INC | 08180820 | NRTI | 2024-04-01 | 2026-03-31 | ORAL | 6 | NRTI | |||||
| 42 | A681HJ | EMTRICITABINE|TENOFOVIR 200MG|300MG TAB (MCP) | EMTRICITABINE|TENOFOVIR | EMTRICITABINE|TENOFOVIR | 30'S | BL | 10.87 | 0.36 | TAB | 60 | BLIS | MCP | MACLEODS PHARMACEUTICALS LTD | AHI | ARMSTRONG HEALTHCARE INC | 08180820 | NRTI | 2026-04-01 | 2028-03-31 | ORAL | 0 | NRTI | |||||
| 40 | A681HK | LOPINAVIR | RITONAVIR 200MG | 50MG TAB (MAT/AHI) | LOPINAVIR|RITONAVIR | LOPINAVIR|RITONAVIR | 120'S | BL | 85.63 | 0.71 | TABLET | 0 | TAB | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 40 | A681HL | EMTRICITABINE | TENOFOVIR 200MG | 300MG TAB (MAT/AHI) | EMTRICITABINE|TENOFOVIR | EMTRICITABINE|TENOFOVIR | 30'S | BL | 29.19 | 0.97 | TABLET | 0 | TAB | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681HL | EMTRICITABINE|TENOFOVIR 200MG|300MG TAB (MAT) (BL) | EMTRICITABINE|TENOFOVIR | EMTRICITABINE|TENOFOVIR | 30'S | BL | 27.67 | 0.9224 | TAB | 60 | BOX | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180820 | NRTI | 2024-04-01 | 2026-03-31 | ORAL | 6 | NRTI | |||||
| 42 | A681HL | EMTRICITABINE|TENOFOVIR 200MG|300MG TAB (MAT) | EMTRICITABINE|TENOFOVIR | EMTRICITABINE|TENOFOVIR | 30'S | BL | 27.67 | 0.92 | TAB | 60 | BLIS | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180820 | NRTI | 2026-04-01 | 2028-03-31 | ORAL | 0 | NRTI | |||||